Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.

Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG.

J Gastrointest Surg. 2012 Apr;16(4):682-91. doi: 10.1007/s11605-011-1808-z. Epub 2012 Feb 17.

PMID:
22350721
2.

Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.

Tsao JI, Rossi RL, Lowell JA.

Arch Surg. 1994 Apr;129(4):405-12. Erratum in: Arch Surg 1994 Nov;129(11):1164.

PMID:
7908796
3.

Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.

Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR.

J Surg Oncol. 2007 Mar 15;95(4):286-90.

PMID:
17326125
4.

Tumors of the ampulla of vater: histopathologic classification and predictors of survival.

Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW.

J Am Coll Surg. 2008 Aug;207(2):210-8. doi: 10.1016/j.jamcollsurg.2008.01.028. Epub 2008 May 5.

PMID:
18656049
5.

Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.

Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL.

World J Surg. 2007 Jan;31(1):137-43; discussion 144-6.

PMID:
17171495
6.

The histopathologic type of the periampullary tumors. Is it important for survival?

Georgescu SO, Neacşu CN, Vintilă D, Popa P, Florea N, Mihailovici MS.

Chirurgia (Bucur). 2009 Nov-Dec;104(6):697-700.

PMID:
20187467
7.

Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Falconi M, Crippa S, Domínguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P.

Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20.

PMID:
18712568
8.

Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?

Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP.

Ann Surg Oncol. 2013 Feb;20(2):430-9. doi: 10.1245/s10434-012-2603-0. Epub 2012 Sep 7.

PMID:
22956064
9.

Periampullary adenocarcinoma: analysis of 5-year survivors.

Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA.

Ann Surg. 1998 Jun;227(6):821-31.

10.

Factors influencing survival after resection for periampullary neoplasms.

Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter DW, Moossa AR.

Am J Surg. 2000 Jul;180(1):13-7.

PMID:
11036132
11.

Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.

Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Shimamoto F, Sueda T.

Dig Dis Sci. 2008 Aug;53(8):2281-6. Epub 2007 Dec 20.

PMID:
18095164
12.

Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.

Wang SE, Shyr YM, Su CH, Chen TH, Wu CW.

Pancreas. 2012 Aug;41(6):882-7. doi: 10.1097/MPA.0b013e31823c9d46.

PMID:
22286381
13.

Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.

Todoroki T, Koike N, Morishita Y, Kawamoto T, Ohkohchi N, Shoda J, Fukuda Y, Takahashi H.

Ann Surg Oncol. 2003 Dec;10(10):1176-83.

PMID:
14654474
14.

Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.

Kim WS, Choi DW, Choi SH, Heo JS, You DD, Lee HG.

J Surg Oncol. 2012 Mar;105(3):266-72. doi: 10.1002/jso.22090. Epub 2011 Aug 31.

PMID:
21882202
15.

Results of surgical treatment of periampullary tumors: a thirty-five-year experience.

Tarazi RY, Hermann RE, Vogt DP, Hoerr SO, Esselstyn CB Jr, Cooperman AM, Steiger E, Grundfest S.

Surgery. 1986 Oct;100(4):716-23.

PMID:
3764694
16.

Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.

Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Tang LH.

J Gastrointest Surg. 2014 Mar;18(3):457-62; discussion 462-3. doi: 10.1007/s11605-014-2456-x. Epub 2014 Jan 22.

PMID:
24448999
17.

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP.

BMC Cancer. 2008 Jun 11;8:170. doi: 10.1186/1471-2407-8-170.

18.

Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.

Winter JM, Cameron JL, Olino K, Herman JM, de Jong MC, Hruban RH, Wolfgang CL, Eckhauser F, Edil BH, Choti MA, Schulick RD, Pawlik TM.

J Gastrointest Surg. 2010 Feb;14(2):379-87. doi: 10.1007/s11605-009-1080-7.

PMID:
19911239
19.

Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.

Shaib WL, Sharma R, Brutcher E, Kim S, Maithel SK, Chen Z, Kooby DA, Kauh J, Landry J, El-Rayes BF.

J Surg Oncol. 2014 May;109(6):556-60. doi: 10.1002/jso.23529. Epub 2013 Dec 11.

PMID:
24338561
20.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101

Supplemental Content

Support Center